Skip to main content Skip to main navigation menu Skip to site footer

About The Journal

Pioneering the Fight Against Cancer: International Journal of Cancer Therapeutics (JCT) by Sciforce Publications

Enter the world of cutting-edge cancer research and therapeutic advancements with the Journal of Cancer Therapeutics (JCT), an esteemed publication by Sciforce Publications. JCT serves as a beacon for the latest research and innovations in the fields of cancer therapeutics, oncology, and the dynamic realm of cancer treatment. In this web content, we will explore the significance of JCT, its contributions to the scientific community, and the inspiring world of cancer therapy.

JCT - Journal of Cancer Therapeutics:

  • A Pillar of Medical Progress: Sciforce Publications is renowned for its commitment to scientific rigor and innovation, and JCT exemplifies this commitment. This journal stands at the forefront of disseminating groundbreaking research in cancer therapeutics.
  • Comprehensive Focus: JCT covers a wide spectrum of topics within cancer research and therapy, including novel treatment approaches, clinical trials, immunotherapy, targeted therapy, and more. It serves as a comprehensive resource for multidisciplinary research.
  • Peer-Reviewed Excellence: Every article published in JCT undergoes a rigorous peer-review process, ensuring that only high-quality, impactful research finds its place in the journal. This commitment to quality establishes JCT as a trusted source of knowledge for researchers, oncologists, healthcare professionals, and cancer patients and their families.

Contributions to Scientific Advancement:

  • Innovative Therapeutic Approaches: JCT showcases pioneering research in cancer therapy, featuring innovative treatment modalities, novel drug candidates, and personalized medicine approaches.
  • Clinical Insights: The journal often features studies that provide valuable insights from clinical trials, helping bridge the gap between laboratory discoveries and patient care.
  • Immunotherapy and Targeted Therapy: Research in JCT explores the burgeoning fields of immunotherapy and targeted therapy, which hold tremendous promise for more effective and less invasive cancer treatments.
  • Supportive Care and Survivorship: JCT examines aspects of supportive care for cancer patients and survivorship, promoting a holistic approach to cancer treatment and quality of life.

Impact on Scientific Progress:

  • The research published in the Journal of Cancer Therapeutics has profound implications for scientific progress:
  • Advancements in Cancer Treatment: JCT plays a pivotal role in advancing cancer therapies, improving treatment outcomes, and enhancing the quality of life for cancer patients.
  • Personalized Medicine: Innovative approaches highlighted in the journal contribute to the development of personalized cancer treatments tailored to individual patient profiles.
  • Patient-Centered Care: JCT fosters scientific progress by providing a platform for researchers to share their discoveries and collaborate on innovative solutions in cancer therapeutics, ultimately benefitting cancer patients and their families.

Our Mission:

Pioneering Progress in Cancer Therapy: Our Mission at the Journal of Cancer Therapeutics (JCT) by Sciforce Publications

At the Journal of Cancer Therapeutics (JCT) by Sciforce Publications, our mission is to be at the forefront of cancer research and therapy. We are dedicated to advancing scientific knowledge, fostering innovation in cancer therapeutics, and contributing to the development of effective treatments and strategies that empower researchers, clinicians, and patients in the fight against cancer.

Our mission is founded on several core principles:

  • Advancing Cancer Therapy: We aim to push the boundaries of cancer therapy through pioneering research. Our mission is to provide a platform for the dissemination of groundbreaking studies that contribute to the understanding and development of innovative therapeutic approaches.
  • Empowering Scientific Discovery: Cancer remains one of the most challenging health issues of our time. We are committed to supporting research that empowers scientists, clinicians, researchers, and innovators to make significant discoveries and advancements in the field of oncology.
  • Promoting Scientific Excellence: Scientific excellence is the cornerstone of our mission. We uphold the highest standards of quality in cancer research. Our goal is to provide a respected platform for researchers, oncologists, and experts to share their pioneering work.
  • Bridging Research and Clinical Practice: We believe in the practical application of research. Our mission is to bridge the gap between cutting-edge discoveries and their real-world applications in clinical practice, facilitating the translation of scientific advancements into effective patient care.
  • Global Impact: JCT is dedicated to serving the global cancer research and medical communities. Our mission is to provide a platform for researchers and professionals from around the world to share their insights, fostering international collaboration and knowledge exchange.
  • Patient-Centric Approach: We prioritize the well-being of cancer patients. Our mission is to promote research that leads to improved treatment options, enhanced quality of life, and increased survivorship, with a focus on patient-centered care.
  • Knowledge Dissemination: We recognize the power of knowledge dissemination. Our mission is to make high-quality cancer research accessible to researchers, clinicians, patients, caregivers, policymakers, and anyone dedicated to the advancement of cancer therapy.

The Journal of Cancer Therapeutics (JCT) by Sciforce Publications is guided by a mission to pioneer progress in cancer therapy. We are dedicated to expanding the horizons of scientific knowledge, promoting innovation in cancer therapeutics, and contributing to a future where cancer is more effectively diagnosed, treated, and prevented. Through our commitment to scientific excellence, a patient-centric approach, and global knowledge dissemination, we aspire to make a profound impact on the field of oncology, enabling discoveries and therapies that improve the lives of individuals and families affected by cancer. Join us in our mission to advance cancer therapy for a brighter and healthier future.

Aim and Scope

Journal of Cancer Therapeutics is a broad field of organic chemistry and its related disciplines such as medicinal chemistry, bio-organic chemistry and pharmaceutical chemistry and it provides a rapid dissemination of original research articles, reviews, short communications, rapid communications and abstracts. Rapid communications and abstracts of such research preserves their research credibility and to transmit their new contributions quickly to other researchers and the public. Cancer is the name given to a collection of related diseases that can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. These extra cells can divide without stopping and may form growths called tumors. “This leads to Cancer”. Cancer cells are also often able to evade the immune system, a network of organs, tissues, and specialized cells that protects the body from infections and other conditions as some cancer cells are able to “hide” from the immune system. The word “Therapeutics” states means the branch of medicine concerned with the treatment of disease and the action of remedial agents and is also stated that serving and caring for the patient in a comprehensive manner, preventing disease as well as managing specific problems.  Cancer Therapeutics the branch that deals specifically with the treatment of cancer and healing by use of drugs and the method of their administration. There are several ranges of treatments which are already available for cancer in recent times which include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy and synthetic lethality. However, there is still a need for further research and new innovation of medicine in treatment of cancer. As per the World Health Organisation, The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in 8 men and one in 11 women die from the disease

Sciforce Journal of Cancer Therapeutics (JCT) journals and research papers are a gateway to the community of Cancer Therapeutics Research experts, researchers and peers. While adhering to the international standards of online publishing, JCT aims to publish high quality, informative, scientific and well-researched content.

Journal of Cancer Therapeutics

  • Cell Cycle and Checkpoints
  • DNA Repair and Apoptosis
  • Nuclear Serine-Threonine Kinases
  • PI3-Akt-mTOR Pathway
  • Signal Transduction and Ubiquitin-related Pathway
  • Cancer Treatments
  • Homeostasis
  • Cancer Trends
  • Cancer Therapeutics
  • Different Types of Cancer
  • Dental Cancer
  • Lung Cancer
  • Breast Cancer
  • Cancer Genetics
  • Tumor Immunology
  • Cancer Drug Discovery
  • Application in Cancer Research
  • Metastasis
  • Cancer Stem Cell Pathway
  • Colorectal Cancer
  • Hepatocellular Carcinoma
  • Genitourinary Cancer

The Journal of Cancer Therapeutics by Sciforce Publications is a guiding light in the dynamic field of cancer research and therapy. Its dedication to scientific excellence, innovation, and impactful research makes it an indispensable resource for scientists, researchers, oncologists, healthcare professionals, and anyone touched by the profound impact of cancer. Explore the pages of JCT to stay updated on the latest developments and breakthroughs in cancer therapeutics, and join the journey toward pioneering the fight against cancer and improving the lives of those affected by this challenging disease.